BERKELEY HEIGHTS, N.J., April 07, 2021 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference taking place on April 12 – 15, 2021.
20th Annual Needham Virtual Healthcare Conference (virtual)
Date: Wednesday, April 14th
Time: 4:30 pm Eastern Time
Webcast: https://wsw.com/webcast/needham107/crmd/2235068
About CorMedix
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product, which provides an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also intends to develop DefenCath as a catheter lock solution for use in oncology and total parenteral nutrition patients. It is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with programs in surgical sutures and meshes, and topical hydrogels. The Company is also working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers. Neutrolin® is CE Marked and marketed in Europe and other territories as a medical device. For more information, visit: www.cormedix.com.
Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
617-430-7576
Hyderabad, India--(Newsfile Corp. - June 29, 2024) - BrandingExperts.com, a leader in digital marketing solutions,…
TIMONIUM, Md., June 28, 2024 /PRNewswire/ -- Psych Associates of Maryland LLC d/b/a Bloom Health…
MEMPHIS, Tenn., June 28, 2024 /PRNewswire/ -- On or about March 14, 2024, through March…
Enrollment of LGBTQIA+ participants in ambitious population genomics study soars to nearly 40,000 using Vibrent’s…
Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE:…
Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…